Multivariate analysis including age (less or more than 65 years), the proof of any multiresistant pathogen, the proof of Candida species, placement of a stent, the primary tumor (pancreatic vs. non-pancreatic), a high bilirubin level (higher than 7 mg/dl) and a high CRP level (higher than 25 mg/l) confirmed the negative impact of a multiresistent pathogen (Hazard Ratio 8.77, p = 0.009) or a high CRP level (Hazard Ratio 2.98, p = 0.041) (Table 3). This evidence concerns the gene CRP and neoplasm.